Recent Blog Articles

Women's Health

Update on osteoporosis treatment

August 01, 2012

Should you stay on bisphosphonate drugs long-term?

You've probably read the news about a recent FDA analysis that questioned whether women with osteoporosis should stay on bisphosphonate drugs for more than five years. If you've been taking these drugs long-term, you might be wondering, "What do I do now?"

"I think this is a very important issue, and certainly one that patients should talk to their physician about," says Dr. Meryl LeBoff, director of the Skeletal Health and Osteoporosis Center and Bone Density Unit at Brigham and Women's Hospital.

To continue reading this article, you must log in.

Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.

  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »

I'd like to receive access to Harvard Health Online for only $4.99 a month.

Sign Me Up

Already a member? Login ».


As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.